SeizureAlert: Intelligent Devices for Epilepsy Monitoring
The market research report on the
Global Epilepsy
Monitoring Devices Market
presents an in-depth information about the various aspects of the market, on
both global and regional scales, which provides a better understanding of the
present market landscape. The growth of the Epilepsy Monitoring Devices market
has been driven by the soaring demand for Epilepsy Monitoring Devices in the
well-established and emerging regions, current technological advancements, and
the growing infiltration of the end-use industries.
The report "Epilepsy Monitoring
Devices Market by Product (Conventional & Wearable Devices, Standard EEG,
Video EEG, Ambulatory EEG, EMG, MEG, Deep Brain Stimulation Devices) End User
(Hospitals, Neurology Centres, ASC, Home Care Settings) - Global Forecast to
2026" The global epilepsy monitoring devices market is projected to reach
USD 615 million by 2026 from USD 489 million in 2021, at a CAGR of 4.7% during
the forecast period. The growth of this market is majorly attributed to the
increasing incidence and prevalence of epilepsy, growing preference for
ambulatory healthcare and increasing use of wearables, growing demand for
continuous monitoring, and the rising awareness of neurodegenerative diseases,
including epilepsy. On the other hand, the high cost of complex epilepsy
monitoring procedures and devices and the unfavorable reimbursement policies
are restraining the growth of this market.
Download a PDF Copy: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=62758189
The report presents some illustrations
and presentations with regard to the market, which includes graphs, tables and
pie charts, representing the percentage split of the strategies adopted by the
key players in the global market. The product launches are regarded as one of
the key strategies adopted by the leading market competitors in the Global Epilepsy
Monitoring Devices Market so as to present novel and innovative products in
different business segments.
Natus Medical, Inc. (US), Compumedics
Limited (Australia), The Magstim Co. Ltd. (UK), Nihon Kohden Corporation
(Japan), and Masimo Corporation (US) were the top players in the epilepsy
monitoring devices market during the forecast period. Other major players in
the market include Empatica, Inc. (US), Medtronic Plc (Ireland), Boston
Scientific Corporation (US), Drägerwerk
AG & Co. KGaA (Germany), mjn Neuroserveis S.L. (Spain), Abbott
Laboratories, Inc. (US), LivAssured B.V. (Netherlands), BioSerenity (France),
Aleva Neurotherapeutics (Switzerland), Medpage, Ltd. (UK), Neurosoft (Russia).
The
research report categorizes the Epilepsy monitoring devices market into the
following segments and subsegments:
By
Product
·
Wearable Devices
·
Conventional Devices
o
Deep Brain Stimulation Devices
o
Monitoring Devices
§ EEG
Devices
·
Standard EEG
·
Video EEG
·
Others/Ambulatory EEG
§ EMG
Devices
§ MEG
Devices
§ Other
Monitoring Devices
By
End User
·
Hospitals
·
Ambulatory Surgery Centers &
Clinics
·
Neurology Centres
·
Diagnostic Centres
·
Home Care Settings
Some of the key geographies mentioned
in this report include:
·
North America (U.S and Canada and rest
of North America)
·
Europe (Germany, France, Italy and Rest
of Europe)
·
Asia-Pacific (China, Japan, India,
South Korea and Rest of Asia-Pacific)
·
LAMEA (Brazil, Turkey, Saudi Arabia,
South Africa and Rest of LAMEA)
Recent Developments
·
In February 2021, BioSerenity and
Premier Inc. entered into an agreement where the former was to serve as Premier’s contracted provider and serve
approximately 4,000 US hospitals and 175,000 other providers.
·
In January 2021, Nihon Kohden launched
disposable EEG electrodes to help prevent cross-contamination between patients
and healthcare workers while maintaining high-quality EEG signals.
·
In July 2020, Magstim acquired Philips’ subsidiary, EGI, adding high-density
EEG solutions to its product portfolio. This acquisition helped the company
close the loop for the development of a comprehensive system for non-invasive
neuromodulation.
·
In May 2020, Natus Medical announced a
partnership with Holberg to develop and distribute the Autoscore algorithm. The
algorithm helps automate electroencephalography (EEG) classifications and
advance reporting efficiency.
Key Deliverables in the Study:
·
Overall market landscape for the Global
Epilepsy Monitoring Devices Market, along with the regional analysis and
competitive analysis, based on the regional and global scales.
·
Market definition and market dynamics,
including drivers, restraints, challenges, threats, and potential growth
opportunities.
·
Factors responsible for changing the
market landscape, soaring opportunities, and identification of leading
competitors that will impact the growth of the market on a regional and global
scale.
·
Detailed analysis of the leading
industry participants along with their company profiles, supply chain trends,
technological advancements, inventions, and key developments.
·
In-depth analysis of the macro- and
micro factors that will have an impact on the growth of the market, on a
regional and global scale.
·
Detailed assessment of the financial
information and the current strategies of the leading key players functioning
in the market.
·
An in-depth understanding and insights
about the key industry players and the strategies adopted by them to sustain
and grow in the Global Epilepsy Monitoring Devices Market.
Research Study Source:
https://www.marketsandmarkets.com/ResearchInsight/epilepsy-monitoring-devices-market.asp
https://www.marketsandmarkets.com/PressReleases/epilepsy-monitoring-devices.asp
Comments
Post a Comment